Antimalarial effect of diaphenylsulfone and three sulfonamides among semi-immune Africans.
D000293:Adolescent; D001741:Black or African American; D044383:Black People; D002648:Child; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007109:Immunity; D008288:Malaria / Q000188:drug therapy*; D013412:Sulfadimethoxine / Q000008:administration & dosage / Q000627:therapeutic use*; D013421:Sulfamethoxypyridazine / Q000008:administration & dosage / Q000627:therapeutic use*; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D013636:Tanzania
D013449:Sulfonamides; D013412:Sulfadimethoxine; D003622:Dapsone; D013421:Sulfamethoxypyridazine